Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 9, 2008, Pages 1624-1634

  Barret, O ^a,b,c,f   Mazere J ^a,b,c   Seibyl, J ^d   Allard, M ^a,b,c,e  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b CNRS UMR5231   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^e PSL RESEARCH UNIVERSITY   (France)

^f HÔPITAL PELLEGRIN   (France)

Author keywords

123I IBVM; Dementia; Human; Non invasive quantification; SPECT; Vesicular acetylcholine transporter

Indexed keywords

IODOBENZOVESAMICOL I 123; RADIOPHARMACEUTICAL AGENT; VESICULAR ACETYLCHOLINE TRANSPORTER;

ARTICLE; CEREBELLUM; CEREBELLUM VERMIS; COMPARTMENT MODEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; THALAMUS;

AGED; BRAIN; DEMENTIA; HUMANS; IODINE RADIOISOTOPES; KINETICS; MODELS, BIOLOGICAL; PIPERIDINES; RADIOPHARMACEUTICALS; TETRAHYDRONAPHTHALENES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 50249180792     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.53     Document Type: Article

References (42)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716-23
2. 3H]Vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse 2:486-93
3. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50:1914-23
4. Bahr BA, Clarkson ED, Rogers GA, Noremberg K, Parsons SM (1992) A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemistry 31:5752-62
5. Bird TD, Stranahan S, Sumi SM, Raskind M (1983) Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 14:284-93
6. Burn DJ (2006) Cortical Lewy Body disease and Parkinson's disease dementia. Curr Opin Neurol 19:572-9
7. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 13:24-42
8. Cook RD (1979) Influential observations in linear regression. J Amer Stat Ass 74:169-74
9. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ (2002) Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 51:145-55
10. Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM (1993) 3D statistical neuroanatomical models from 305 MRI volumes. Proc IEEE NSS/MIC Conf 1813-7
11. 2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696-708
12. Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI (1999) Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 411:693-704
13. 11C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab 21:1342-53
14. 11C]WAY-100635 for PET. Neuroimage 8:426-440
15. Herholz K, Weisenbach S, Kalbe E, Diederich NJ, Heiss WD (2005) Cerebral acetylcholine esterase activity in mild cognitive impairment. Neuroreport 16:1431-4
16. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47-54
17. 2 receptors with iodine-123-IBF SPECT. J Nucl Med 37:513-20
18. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-112
19. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-9
20. 11C]raclopride binding. J Cereb Blood Flow Metab 18:941-50
21. Jung YW, Van Dort ME, Gildersleeve DL, Wieland DM (1990) A radiotracer for mapping cholinergic neurons of the brain. J Med Chem 33:2065-8
22. 11C]flumazenil and kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735-44
23. Kuhl DE, Koeppe R, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52:691-9
24. Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, Gildersleeve DL, Frey KA, Wieland DM (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35:405-10
25. Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 40:399-410
26. 11C] raclopride studies. J Cereb Blood Flow Metab 16:42-52
27. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-8
28. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab 14:439-52
29. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-7
30. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-40
31. Marquardt DW (1963) An algorithm for least-squares estimation on non-linear parameters. J Soc Ind Appl Math 11:431-41
32. 123I]-IBVM in early Alzheimer's disease. Neuroimage 40:280-8
33. McGeer PL, Eccles SJC, McGeer EG (1980) Molecular neurobiology of the mammalian brain. New York: Plenum Press
34. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-27
35. Patlak CS, Blasberg RG, Fenstermacher JD (1993) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
36. Rees TM, Brimijoin S (2003) The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease. Drugs Today (Barc) 39:75-83
37. Slifstein M, Laruelle M (2001) Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 28:595-608
38. Studholme C, Hill DLG, Hawkes DJ (1999) An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognition 32:71-86
39. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-89
40. 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. Nucl Med Biol 20:929-37
41. Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22:1440-52
42. Zea-Ponce Y, Mavel S, Assaad T, Kruse SE, Parsons SM, Emond P, Chalon S, Giboureau N, Kassiou M, Guilloteau D (2005) Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter. Bioorg Med Chem 13:745-53